NO971203L - Scopolamin-plaster - Google Patents

Scopolamin-plaster

Info

Publication number: NO971203L
Authority: NO; Norway
Prior art keywords: scopolamine; patch; saturation solubility; base; scopolamine patch
Prior art date: 1994-09-16

Application number

NO971203A

Other languages

English (en)

Other versions

NO312496B1 (no

NO971203D0 (no

Inventor

Walter Mueller

Original Assignee

Lohmann Therapie Syst Lts

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-16

Filing date

1997-03-14

Publication date

1997-03-14

1994-10-31 Priority claimed from DE4438989A external-priority patent/DE4438989C2/de

1997-03-14 Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts

1997-03-14 Publication of NO971203D0 publication Critical patent/NO971203D0/no

1997-03-14 Publication of NO971203L publication Critical patent/NO971203L/no

2002-05-21 Publication of NO312496B1 publication Critical patent/NO312496B1/no

Links

229930000680 A04AD01 - Scopolamine Natural products 0.000 title abstract 3
STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 title abstract 3
STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 title abstract 3
STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 title abstract 3
229960002646 scopolamine Drugs 0.000 title abstract 3
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 abstract 1
NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 abstract 1
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
229920005601 base polymer Polymers 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Otolaryngology (AREA)
Hospice & Palliative Care (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Polyurethanes Or Polyureas (AREA)
Saccharide Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Inks, Pencil-Leads, Or Crayons (AREA)

NO19971203A 1994-09-16 1997-03-14 Scopolamin-plaster NO312496B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE4433004		1994-09-16
DE4438989A DE4438989C2 (de)	1994-09-16	1994-10-31	Scopolaminpflaster
PCT/EP1995/003555 WO1996008251A1 (de)	1994-09-16	1995-09-09	Scopolaminpflaster

Publications (3)

Publication Number	Publication Date
NO971203D0 NO971203D0 (no)	1997-03-14
NO971203L true NO971203L (no)	1997-03-14
NO312496B1 NO312496B1 (no)	2002-05-21

Family

ID=25940173

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19971203A NO312496B1 (no)	1994-09-16	1997-03-14	Scopolamin-plaster

Country Status (20)

Country	Link
US (1)	US5714162A (no)
EP (1)	EP0781134B9 (no)
JP (1)	JP4466977B2 (no)
CN (1)	CN1087938C (no)
AT (1)	ATE262333T1 (no)
AU (1)	AU695698B2 (no)
CA (1)	CA2200189C (no)
CZ (1)	CZ289313B6 (no)
DE (1)	DE59510883D1 (no)
ES (1)	ES2219665T3 (no)
FI (1)	FI118885B (no)
HU (1)	HUT77383A (no)
IL (1)	IL115189A (no)
MX (1)	MX9701968A (no)
MY (1)	MY112477A (no)
NO (1)	NO312496B1 (no)
NZ (1)	NZ292921A (no)
PL (1)	PL182158B1 (no)
SK (1)	SK282640B6 (no)
WO (1)	WO1996008251A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19738643C2 (de) *	1997-09-04	2001-10-04	Lohmann Therapie Syst Lts	Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung
US6087341A (en) *	1998-02-12	2000-07-11	The Board Of Trustees Of The Leland Standford Junior University	Introduction of nucleic acid into skin cells by topical application
US20020119187A1 (en) *	2000-09-29	2002-08-29	Cantor Adam S.	Composition for the transdermal delivery of fentanyl
US20050208117A1 (en) *	2001-03-16	2005-09-22	Venkatraman Subramanian S	Transdermal administration of fentanyl and analogs thereof
KR100904158B1 (ko) *	2001-03-16	2009-06-23	알자 코포레이션	펜타닐 투여용 경피성 패치
DE10141650C1 (de)	2001-08-24	2002-11-28	Lohmann Therapie Syst Lts	Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
EP1613297B1 (en) *	2003-04-14	2007-06-06	LTS Lohmann Therapie-Systeme AG	Therapeutic patch with polysiloxane matrix comprising capsaicin
AU2004231740A1 (en) *	2003-04-17	2004-11-04	The Trustees Of Columbia University In The City Ofnew York	Desmoglein 4 is a novel gene involved in hair growth
CA2557532A1 (en) *	2004-04-23	2005-11-10	Angela M. Christiano	Inhibition of hairless protein mrna
FR2884143B1 (fr) *	2005-04-08	2007-06-22	Millet Innovation Sa	Timbre dermique rechargeable
US20070010550A1 (en) *	2005-07-08	2007-01-11	The Board Of Regents Of The University Of Texas	Scopolamine to Reduce or Eliminate Hot Flashes, Night Sweats, and Insomnia
CA2643037C (en) *	2006-02-27	2014-08-05	Noven Pharmaceuticals, Inc.	Compositions and methods for delivery of amino-functional drugs
DE102006028987A1 (de) *	2006-06-24	2007-12-27	Lts Lohmann Therapie-Systeme Ag	Ultraschallverstärktes transdermales therapeutisches System
MY154027A (en) *	2007-10-15	2015-04-30	Alza Corp	Once-a-day replacement transdermal administration of fentanyl
CN102764342B (zh) *	2012-07-17	2013-12-04	陈鼎汉	治疗褥疮、糖尿病伤口、烫伤的药膏
WO2020189323A1 (ja)	2019-03-19	2020-09-24	ノーベルファーマ株式会社	薬物の生体への吸収性に優れ、且つ、化学的安定性にも優れる医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL8104929A (nl) *	1980-11-12	1982-06-01	Alza Corp	Anticholinergische preparaten, alsmede de bereiding en de toepassing ervan.
US5310559A (en) *	1982-09-01	1994-05-10	Hercon Laboratories Corporation	Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
US4832953A (en) *	1987-08-13	1989-05-23	Alza Corporation	Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
US5474783A (en) *	1988-03-04	1995-12-12	Noven Pharmaceuticals, Inc.	Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE58906975D1 (de) *	1988-08-02	1994-03-24	Ciba Geigy	Mehrschichtiges Pflaster.
DE3908431A1 (de) *	1989-03-15	1990-09-27	Lohmann Therapie Syst Lts	Transdermales system mit gestufter wirkstoffabgabe und verwendung fuer die lokale oder systemische wirkstoffverabreichung
US5176917A (en) *	1989-03-15	1993-01-05	Lts Lohmann	Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
JPH04261119A (ja) *	1991-02-13	1992-09-17	Lintec Corp	経皮吸収型貼付剤

1995
- 1995-01-05 US US08/369,019 patent/US5714162A/en not_active Expired - Lifetime
- 1995-09-06 IL IL11518995A patent/IL115189A/xx not_active IP Right Cessation
- 1995-09-06 MY MYPI95002638A patent/MY112477A/en unknown
- 1995-09-09 CN CN95195097A patent/CN1087938C/zh not_active Expired - Fee Related
- 1995-09-09 JP JP50989096A patent/JP4466977B2/ja not_active Expired - Lifetime
- 1995-09-09 HU HU9701966A patent/HUT77383A/hu not_active Application Discontinuation
- 1995-09-09 EP EP95932020A patent/EP0781134B9/de not_active Expired - Lifetime
- 1995-09-09 CA CA002200189A patent/CA2200189C/en not_active Expired - Fee Related
- 1995-09-09 WO PCT/EP1995/003555 patent/WO1996008251A1/de not_active Ceased
- 1995-09-09 MX MX9701968A patent/MX9701968A/es not_active IP Right Cessation
- 1995-09-09 SK SK338-97A patent/SK282640B6/sk unknown
- 1995-09-09 NZ NZ292921A patent/NZ292921A/en not_active IP Right Cessation
- 1995-09-09 CZ CZ1997757A patent/CZ289313B6/cs not_active IP Right Cessation
- 1995-09-09 AU AU35231/95A patent/AU695698B2/en not_active Ceased
- 1995-09-09 ES ES95932020T patent/ES2219665T3/es not_active Expired - Lifetime
- 1995-09-09 PL PL95319259A patent/PL182158B1/pl not_active IP Right Cessation
- 1995-09-09 AT AT95932020T patent/ATE262333T1/de not_active IP Right Cessation
- 1995-09-09 DE DE59510883T patent/DE59510883D1/de not_active Expired - Lifetime
1997
- 1997-03-14 NO NO19971203A patent/NO312496B1/no unknown
- 1997-03-14 FI FI971097A patent/FI118885B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI118885B (fi)	2008-04-30
NO312496B1 (no)	2002-05-21
AU3523195A (en)	1996-03-29
EP0781134B1 (de)	2004-03-24
ES2219665T3 (es)	2004-12-01
IL115189A (en)	1999-12-22
DE59510883D1 (de)	2004-04-29
FI971097L (fi)	1997-03-14
CA2200189A1 (en)	1996-03-21
CZ75797A3 (en)	1997-07-16
CN1087938C (zh)	2002-07-24
MY112477A (en)	2001-06-30
NO971203D0 (no)	1997-03-14
SK33897A3 (en)	1997-09-10
AU695698B2 (en)	1998-08-20
CN1158084A (zh)	1997-08-27
FI971097A0 (fi)	1997-03-14
IL115189A0 (en)	1995-12-31
WO1996008251A1 (de)	1996-03-21
US5714162A (en)	1998-02-03
CA2200189C (en)	2008-06-17
PL182158B1 (pl)	2001-11-30
CZ289313B6 (cs)	2001-12-12
JP4466977B2 (ja)	2010-05-26
PL319259A1 (en)	1997-08-04
JPH10505825A (ja)	1998-06-09
MX9701968A (es)	1998-02-28
EP0781134B9 (de)	2004-09-29
SK282640B6 (sk)	2002-10-08
HUT77383A (hu)	1998-04-28
EP0781134A1 (de)	1997-07-02
ATE262333T1 (de)	2004-04-15
NZ292921A (en)	1998-09-24

Publication	Publication Date	Title
AU695698B2 (en)	1998-08-20	Scopolamine patch
US6558695B2 (en)	2003-05-06	Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
EA199900553A1 (ru)	1999-12-29	Чрескожная терапевтическая система
ATE238778T1 (de)	2003-05-15	Transdermales therapeutisches system zur abgabe von hormonen
ATE258426T1 (de)	2004-02-15	Zusammensetzungen und verfahren zur topischen anwendungen von wirkstoffen
DE69401945D1 (de)	1997-04-10	Einarbeitung eines poly-n-vinylamids in ein transdermales system
MY106628A (en)	1995-06-30	Estrogen-containing active substance plaster
ATE204467T1 (de)	2001-09-15	Orale darreichungsform
FI904358A0 (fi)	1990-09-04	Transdermalt multipolymert administrationssystem foer laekemedel.
ATE89755T1 (de)	1993-06-15	Vorrichtung zur transdermalen applikation von medikamenten.
ATE63220T1 (de)	1991-05-15	Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben.
ATE231388T1 (de)	2003-02-15	Lang wirksames mittel zur rektalen verabreichung
DE50014495D1 (de)	2007-08-30	Transdermales therapeutisches system mit einer selbstklebenden matrix, enthaltend organische säure-additionssalze von alkaloiden des morphin- bzw. morphinantyps
ATE190828T1 (de)	2000-04-15	Molekulares transdermales transportsystem
ATE294568T1 (de)	2005-05-15	Zusammensetzung zur behandlung von verbrennungen
RU95109228A (ru)	1997-06-10	Способ лечения трофических язв
PL332035A1 (en)	1999-08-16	Transdermal therapeutic system including an estriol-containing composition of active substances
ATE212222T1 (de)	2002-02-15	Zusammensetzungen zur transdermalen und dermalen verabreichung von biologisch wirksamen stoffen